XOMAP
Price:
$24.98
Market Cap:
$503.77M
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty...[Read more]
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
NASDAQ
Ticker
XOMAP
According to XOMA Royalty Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.59. This represents a change of -8.83% compared to the average of 3.94 of the last 4 quarters.
The mean historical Current Ratio of XOMA Royalty Corporation over the last ten years is 6.27. The current 3.59 Current Ratio has changed 5.62% with respect to the historical average. Over the past ten years (40 quarters), XOMAP's Current Ratio was at its highest in in the September 2022 quarter at 14.70. The Current Ratio was at its lowest in in the December 2016 quarter at 0.84.
Average
6.27
Median
6.96
Minimum
0.84
Maximum
8.98
Discovering the peaks and valleys of XOMA Royalty Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 612.67%
Maximum Annual Current Ratio = 8.98
Minimum Annual Increase = -73.05%
Minimum Annual Current Ratio = 0.84
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.37 | -34.65% |
| 2024 | 5.15 | -40.65% |
| 2023 | 8.68 | -3.35% |
| 2022 | 8.98 | 20.13% |
| 2021 | 7.48 | 4.47% |
| 2020 | 7.16 | 5.94% |
| 2019 | 6.76 | -19.08% |
| 2018 | 8.35 | 40.25% |
| 2017 | 5.95 | 612.67% |
| 2016 | 0.84 | -73.05% |
The current Current Ratio of XOMA Royalty Corporation (XOMAP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.73
5-year avg
6.73
10-year avg
6.27
XOMA Royalty Corporation’s Current Ratio is less than Tectonic Therapeutic, Inc. (22.29), less than Aldeyra The (4.91), less than Amarin Corporation plc (3.67), greater than AC Immune S.A. (0.93), less than Lyell Immunopharma, Inc. (5.36), greater than Genelux Corporation (2.39), less than Silence Therapeutics plc (7.42), greater than Cellectis S.A. (1.37), less than Larimar Therapeutics, Inc. (4.70), less than Kyverna Therapeutics, Inc. (9.06),
| Company | Current Ratio | Market cap |
|---|---|---|
| 22.29 | $499.56M | |
| 4.91 | $81.43M | |
| 3.67 | $277.15M | |
| 0.93 | $266.14M | |
| 5.36 | $262.32M | |
| 2.39 | $113.89M | |
| 7.42 | $580.98M | |
| 1.37 | $153.64M | |
| 4.70 | $396.72M | |
| 9.06 | $430.76M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Royalty Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Royalty Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is XOMA Royalty Corporation's Current Ratio?
How is the Current Ratio calculated for XOMA Royalty Corporation (XOMAP)?
What is the highest Current Ratio for XOMA Royalty Corporation (XOMAP)?
What is the 3-year average Current Ratio for XOMA Royalty Corporation (XOMAP)?
What is the 5-year average Current Ratio for XOMA Royalty Corporation (XOMAP)?
How does the current Current Ratio for XOMA Royalty Corporation (XOMAP) compare to its historical average?